KinBio
Nitzan Levy is an experienced biotechnology executive currently serving as General Manager at KinBio since January 2019, leading the company's biopharmaceutical development and manufacturing efforts. Prior experience includes founding ProBio in 2018 and serving as CEO of IBS Ltd from June 2017 to December 2018, as well as holding various leadership roles at InSight Biopharmaceutical Ltd, including Deputy CEO and Director of Process Development from 2009 to 2018. Nitzan Levy also had significant responsibilities as Operations Manager, Scale Up and Engineering Manager, and Production Manager, overseeing biological and chemical production plants. Earlier career experience includes Head of R&D at Insense Biosensors Ltd, focusing on the development of biological sensors. Nitzan Levy holds a Ph.D. in Endocrinology from The Hebrew University of Jerusalem and completed a postdoctoral fellowship at the University of California, San Francisco.
This person is not in any teams
This person is not in any offices
KinBio
KinBio is a rapidly growing biotechnology company based in Rehovot, Israel focusing on developing biopharmaceuticals. Through our experienced team members, KinBio has fostered and developed a large portfolio of technologies for manufacturing generic versions of complex drugs, high quality biosimilars and biologics. Augmented by our global partnerships, KinBio is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoperosis. Our state of the art cGMP manufacturing plants consists of separate suites for the manufacturing of multi-product biologics bulk drug substances (BDS) and chemical synthesis active pharmaceutical ingredients (APIs) through FDA approved fully fledged sterile drug products plants.